Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Medical device company raises $87M to study new-look scaffolds for BTK PAD
R3 Vascular also announced that Christopher M. Owens, a veteran of the medical device industry, is its new president and CEO.
FDA warns against use of troubled heart devices, citing ‘continued concerns’ after multiple recalls
The agency is urging healthcare providers to transition away from these devices and seek out alternatives. It is even working with other manufacturers to try and get similar products on the market as quickly as possible.
Health disparities are causing serious harm, leading to 400 amputations per day
Interventional cardiologist Foluso Fakorede, MD, says everything from limited specialists to a lack of sidewalks are causing a disproportionate rate of minorities to be caught in the current PAD and CLI epidemic.
Moderate aortic stenosis linked to heightened risk of death—should TAVR, surgery be considered?
Researchers tracked data from more than 400,000 patients for a new meta-analysis, presenting their findings in the Journal of the American Heart Association.
Dual-action thrombectomy device could give cardiologists a new tool for treating acute PE
The new device is believed to be the first of its kind, using both aspiration and mechanical clot disruption to remove blood clots.

Ramon Varcoe explains the LIFE-BTK trial for the Abbott Esprit fully bioresobable scaffold at TCT23.

Fully bioresorbable stents boost care for CLI patients in LIFE-BTK trial

Ramon Varcoe, MBBS, co-principal investigator for the LIFE-BTK trial, discussed the results with Cardiovascular Business at TCT 2023. "I can't wait to start using these in my patients. It's going to make a huge difference."

November 14, 2023

Rasha Al-Lamee, MBBS, PhD, a cardiologist with the National Heart and Lung Institute in London, presented ORBITA, commented on the ORBITA-2 findings at the American Heart Association (AHA) 2023 meeting. #AHA #AHA23 #AHA2023

PCI benefits patients with stable chest pain, late-breaking data confirm

“Going forward, patients and medical teams have a choice of two pathways for chest pain relief: chest pain medication or PCI," one cardiologist said.

November 13, 2023

Medtronic Onyx Frontier DES stent with an enlarged 3D print of the stent used in bifurcation stenting. Photo by Dave Fornell

PHOTO GALLERY: Interventional cardiology technologies at TCT 2023

Browse through some of the many highlights from TCT 2023 in San Francisco.

November 9, 2023

Matthias Götberg discusses iFR vs. FFR from the National SWEDEHEART Quality Registry at #TCT2023. #iFR

iFR and FFR are equal, new long-term analysis confirms

There were some concerns among researchers after one study suggested iFR may increase the risk of mortality. New data presented at TCT 2023, however, showed that the two technologies are linked to similar outcomes.

November 8, 2023

The U.S. Food and Drug Administration (FDA) has approved Recor Medical’s Paradise Ultrasound Renal Denervation (RDN) system for uncontrolled hypertension. The Recor system gained FDA clearance in November 2023.

FDA approves first renal denervation system for uncontrolled hypertension

The system, designed for patients with uncontrolled hypertension who are unresponsive to medication, uses ultrasound ablation to target nerves in the renal arteries, increasing blood flow. This approval comes just months after an FDA advisory panel voted in favor of the system.

November 8, 2023

FDA announces Class I recall of nearly 2,000 catheter kits

Medical facilities and distributors have been advised to immediately discontinue the use of these devices due to a significant labeling issue.

November 7, 2023

Example of intravascular ultrasound (IVUS) shown as part of the multimodality imaging capability on the Fujifilm CVIS.

IVUS-guided PCI boosts 2-year survival, reduces need for bypass surgery

IVUS was especially effective when treating patients with a complex coronary anatomy, researchers found.

November 2, 2023

TAVR patients with cancer face higher risks of hospital readmission, serious bleeding

Short-term mortality, however, does not appear to change when TAVR patients present with active cancer.

November 1, 2023

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Interventional Cardiology

Medical device company raises $87M to study new-look scaffolds for BTK PAD

FDA warns against use of troubled heart devices, citing ‘continued concerns’ after multiple recalls

Health disparities are causing serious harm, leading to 400 amputations per day

Moderate aortic stenosis linked to heightened risk of death—should TAVR, surgery be considered?

Dual-action thrombectomy device could give cardiologists a new tool for treating acute PE

Around the web